Axsome Therapeutics, Inc.
Clinical trials sponsored by Axsome Therapeutics, Inc., explained in plain language.
-
New pill could help night shift workers beat extreme sleepiness
Symptom relief Recruiting nowThis study tests a medication called solriamfetol to see if it can help people with shift work disorder stay awake during their night shifts. About 520 adults who struggle with excessive sleepiness due to their work schedule will take either the drug or a placebo for 12 weeks. Th…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 04:34 UTC
-
Could a new pill curb binge eating? phase 3 trial launches
Symptom relief Recruiting nowThis study tests whether the drug solriamfetol can help adults with binge eating disorder (BED) have fewer binge episodes. About 450 people aged 18 to 55 will receive either the drug or a placebo for 12 weeks. The main goal is to see if the drug reduces the number of binge eating…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC
-
New hope for tired minds: drug targets sleepiness in depression
Symptom relief Recruiting nowThis study tests whether solriamfetol can help people with major depression who also feel very sleepy during the day. About 508 adults will take the drug or a placebo to see if it delays the return of depressive symptoms. The goal is to improve energy and mood without requiring l…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 18, 2026 12:09 UTC
-
New fibromyalgia drug shows promise in major trial
Symptom relief Recruiting nowThis study tests an experimental drug called AXS-14 for managing fibromyalgia, a condition that causes widespread pain and fatigue. About 620 adults with fibromyalgia will take the drug or a placebo to see if it helps control symptoms longer. The main goal is to measure how long …
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC